As you’ve likely heard, our children, ages 5 to 12, are now eligible to be double jabbed with the COVID-19 vaccines per federal and CDC guidelines. And as such, the debate has begun on whether or not children in schools should be forced to get it.
Unsurprisingly, Big Tech companies like Pfizer are all for it, as they stand to make billions off of the endeavor.
But if you’re still hesitant about injecting your child with an unknown cocktail of chemicals, Pfizer wants to calm your nerves and offer proof that their BioNTech vaccine is both safe and effective in adolescents. To do so, they have recently released a four-month study showing that the rate of COVID infection is higher in children who were not vaccinated when compared to those that were.
The only problem? Well, that rate of difference isn’t all that different.
Per the study, 2,228 kids between the ages of 12 to 15 were assessed for a period of four months. As with most studies, about half of the students were vaccinated, and the other half were not.
Of the 1,100 who were, none tested positive during the months of the study. In contrast, 30 of those who weren’t vaccinated did end up testing positive.
By Pfizer’s line of thinking, this means that their vaccine is indeed safe and effective, even for the ‘long term.’
According to Pfizer Chairman and CEO Albert Bourla, this study and its data offer “confidence” in the safety and efficacy of the vaccine in adolescents.
But you might notice that 30 positive tests, all of which were either asymptomatic or had very mild symptoms, is only a small percentage. Only 2.7 percent, in fact. So yeah, while Pfizer can say their vaccine supposedly works, it only works about 2.7 percent more than having no vaccine at all.
Starting to feel more secure in the vaccine’s effectiveness in children?
I didn’t think so.
Furthermore, as I mentioned, the study was conducted over a mere four-month time span. And as several social media users noted, that’s not exactly ‘long term.’
And that is the number one reason why Dr. Douglas Opel, interim director at the Treuman Katz Center for Pediatric Bioethics at Seattle Children’s Hospital, says he doesn’t think vaccines should be mandated for schools.
He said, “I think it’s premature to mandate COVID-19 vaccines for elementary and high school students. A primary reason for my position is that a prerequisite for mandating a vaccine is having really high confidence that it’s safe – and we’re just still gathering this data for younger age groups.”
Wendy Jonathan, a Desert Sands Unified School District Trustee, agrees, saying that while the vaccine might be good for some, she can’t in good conscience mandate it for all. “I’ve made my choices, but my choices don’t need to be imposed on anyone else.” Especially with so little information on its long-term effects.
What a concept, huh? That people should be given a choice to vaccinate or not, to take extra health precautions or not. I mean, isn’t that what the same group of liberals demand when it comes to the idea of abortion? That it’s a choice?
But I digress…
It should also be noted that this study just happened to come out just before the company is set to send their double shot and supposedly child-friendly vaccine to the Food and Drug Administration or FDA to be fully approved. Right now, the use of the vaccine is only authorized under the Emergency Use authorization.
As Bourla says, he and Ugur Sahin, the CEO and co-founder of BioNTech, are really excited about “sharing these data with the FDA and other regulators.”
Of course, they are. I mean, when the data is shared, the FDA is likely to do exactly what Pfizer did and take this measly amount of information as proof that their efforts can quash COVID. And if that happens, the FDA’s approval will only do more to convince our liberal leaders that vaccines should be mandated, even for the most innocent and vulnerable of us.
We can only hope that the FDA and other regulators will demand more data and more actual long-term results before agreeing to anything that could possibly endanger the lives of our kids.